Analytical methods
Standard exon sequencing combined with western blot analysis are performed as routine tests. 6 
Analytical validation
Sequencing results are confirmed by exon sequencing using different sets of primers. RT-PCR sequencing may be performed to confirm potential splicing mutations. For potential missense mutations, enzyme assays and protein stability may be performed on a research basis using recombinant WRN protein containing the mutations. 6 If genomic rearrangements are suspected, high-density array CGH can be performed.
Estimated frequency of the disease (Incidence at birth ('birth prevalence') or population prevalence)
The population prevalence of Werner Syndrome is unknown. However, it is likely under-diagnosed because of the lack of awareness of this disorder and the relatively nonspecific symptoms (absence of pathognomonic signs).
If applicable, prevalence in the ethnic group of investigated person
The prevalence of heterozygous carriers in Japan is approximately 1/167 and it is estimated to be approximately 1/120 in Sardinia. 4, 5 1.10 Diagnostic setting
Comment: This is an adult-onset disorder. The earliest sign is the lack of growth spurt during adolescence. Onset of a prematurely agedappearance (grey hair, scleroderma-like skin) typically starts in the 20-30 s followed by the appearance of age-related disorders (cataracts, diabetes mellitus, atherosclerosis, cancers, osteoporosis). 
TEST CHARACTERISTICS
Negative C D Positive predictive value: Negative predictive value:
2. 
Clinical specificity (proportion of negative tests if the disease is not present)
The clinical specificity can be dependent on variable factors such as age or family history. In such cases a general statement should be given, even if a quantification can only be made case by case.
Undefined.
Positive clinical predictive value (lifetime risk to develop the disease if the test is positive)
Undefined. Based on the studies of large pedigrees, most, if not all patients appear to develop symptoms in time.
Negative clinical predictive value (Probability not to develop the disease if the test is negative)
Assume an increased risk based on family history for a non-affected person. Allelic and locus heterogeneity may need to be considered.
Index case in that family had been tested Undefined. Index case in that family had not been tested Undefined. An increase in structural chromosomal aberrations (termed variegated translocation mosaicism) in lymphocyte and fibroblast cultures from individuals with Werner Syndrome is characteristically observed, but is not diagnostic for the condition. 7, 8 3.1.3 How is the cost effectiveness of alternative diagnostic methods to be judged? Either genetic testing or clinical criteria can miss some individuals with Werner Syndrome. Gene testing that identifies pathogenic WRN mutations in patients can be used to help confirm both a clinical diagnosis of Werner Syndrome, and the subsequent low risk of this recessive disease in offspring. Atypical Werner Syndrome is a heterogeneous group of conditions with progeroid features often lacking cataracts with earlier onset during 1st or 2nd decades of life, and in which WRN mutations are absent. The most commonly identified cause of atypical Werner Syndrome is a LMNA mutation, where offspring are at 50% risk. 9 Other possible phenocopies include: Aicardi-Goutieres syndrome or lipodystrophy with mandibuloacral dysplasia caused by a POLD1 mutation. A positive genetic test will alert care providers to the diagnosis of Werner Syndrome. Median lifespan of the patients is 54 years, 3 7 years older than in the report in 1966. 14 Similarly, the median lifespan of Japanese
CLINICAL UTILITY
Werner patients was 53 years. 15 The most frequent causes of deaths are cancers and myocardial infarction.
Management (please describe)
The results of genetic testing can provide a rational basis for regular medical screening for known, common medical conditions seen in Werner Syndrome patients, and increase awareness of potential challenges in treatment.
There are case reports of special challenges in, for example, the surgical management of leg ulcers and revascularization procedures in patients with Werner Syndrome. 16, 17 Cells from Werner Syndrome patients, and presumably the patients themselves, are selectively hypersensitive to some types of DNA damage, including damage mediated by cancer chemotherapy agents such as cis-Pt, mitomycin-C and camptothecin and its derivatives. There is anecdotal evidence suggesting patients may be hypersensitive to the same agents, and thus at elevated risk of treatment-related toxicity. 18 
Predictive setting:
The tested person is clinically unaffected but carries an increased risk based on family history (To be answered if in 1.10 'B' was marked)
Will the result of a genetic test influence lifestyle and prevention?
If the test result is positive (please describe) If the result is positive, this confirms the diagnosis of Werner Syndrome, and as the manifestations occur over many years, lifestyle changes and preventative measures may be instituted. These include smoking avoidance, maintaining a healthy weight, treatment of hyperlipidaemia if present and regular exercise to reduce risk of atherosclerosis and type 2 diabetes. Skin care, with avoidance of trauma, and early, aggressive treatment of skin ulcers helps to reduce morbidity from this complication. Annual ophthalmologic exam for cataracts, lipid profile, diabetes and hypertension screening are recommended when the diagnosis if confirmed.
If the test result is negative (please describe) If the test result is negative, this reduces the likelihood of Werner Syndrome, but should lead to consideration of other diagnoses such as atypical Werner Syndrome resulting from a LMNA mutation. Symptomatic treatment of clinically significant conditions (diabetes, hyperlipidaemia, cataracts) is still indicated. Yes. However, because of the adult-onset of the condition, prenatal testing is rarely indicated as subsequent sibs likely have already been born. Because of the autosomal recessive nature of the condition, children of an affected index patient are obligate carriers, but unlikely to be affected.
IF APPLICABLE, FURTHER CONSEQUENCES OF TESTING
Please assume that the result of a genetic test has no immediate medical consequences. Is there any evidence that a genetic test is nevertheless useful for the patient or his/her relatives? (Please describe)
Although there is no cure for Werner Syndrome, the diagnosis helps to guide appropriate medical management and screening for diseases common in persons with Werner Syndrome (regular exams for cataracts, screening for diabetes, atherosclerosis). Treatment in general is similar to the general population. An affected person could learn that his or her children are unlikely to be affected by Werner Syndrome.
